Axonis Therapeutics Announces $115 Million Series A Financing

PR NewswireOct 30 18:00

Leerink Partners Maintains Pharvaris(PHVS.US) With Buy Rating, Announces Target Price $30

Futu NewsOct 24 23:31 · Ratings

Pharvaris's Promising Developments in HAE Treatment Drive Buy Rating

TipRanksOct 24 22:37 · Ratings

Pharvaris Presents Clinical And Non-Clinical Data Supporting HAE Development Program At The 2024 ACAAI Annual Scientific Meeting

BenzingaOct 24 20:04

Pharvaris to Host Virtual Investor Event on October 23, 2024

GlobeNewswireOct 15 18:50

Oppenheimer Maintains Pharvaris(PHVS.US) With Buy Rating, Maintains Target Price $42

Futu NewsOct 14 20:35 · Ratings